1. CD109 and squamous cell carcinoma
    Ruixia Qi et al, 2018, Journal of Translational Medicine CrossRef
  2. A Significance of Concomitant BRAFV600E and TERT Mutations in Polish Patients with Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Based on 430 Cases
    Artur Kuchareczko et al, 2022, Thyroid CrossRef
  3. A meta-analysis evaluating the relationship between B-type Raf kinase mutation and cervical lymphatic metastasis in papillary thyroid cancer
    Hongzhi Ma et al, 2020, Medicine CrossRef
  4. Do BRAFV600E mutation and sodium-iodide symporter expression affect the response to radioactive iodine therapy in patients with papillary thyroid carcinoma?
    Rania Makboul et al, 2020, Nuclear Medicine Communications CrossRef
  5. Genetic Changes in Thyroid Cancers and the Importance of Their Preoperative Detection in Relation to the General Treatment and Determination of the Extent of Surgical Intervention—A Review
    Jiri Hlozek et al, 2022, Biomedicines CrossRef
  6. Thyroglobulin Antibody (TgAb) Positive is an Independent Risk Factor for Lymph Node Metastasis in Patients with Differentiated Thyroid Carcinoma
    Yeqian Lai et al, 2023, International Journal of General Medicine CrossRef

  7. Serum Tumor Markers for Early Diagnosis of Primary Hepatocellular Carcinoma


    Jingjing Zong et al, 2020, Journal of Hepatocellular Carcinoma CrossRef
  8. BRAF V600E Mutation in Papillary Thyroid Cancer and Its Effect on Postoperative Radioiodine ( 131 I) Therapy: Should We Modify Our Therapeutic Strategy?
    Maite Domínguez Ayala et al, 2018, Cirugía Española (English Edition) CrossRef
  9. CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma
    Xue-Tang Mo et al, 2020, British Journal of Cancer CrossRef
  10. Conventional papillary thyroid carcinoma with intraglandular lymphatic dissemination shows more aggressive features
    Yuanyuan Lei et al, 2022, Japanese Journal of Clinical Oncology CrossRef
  11. BRAFv600e mutation combined with thyroglobulin and fine-needle aspiration in diagnosis of lymph node metastasis of papillary thyroid carcinoma
    Jianming Li et al, 2018, Pathology - Research and Practice CrossRef
  12. Mutación del gen BRAF V600E en el cáncer papilar de tiroides y su efecto en la terapia con yodo radiactivo ( 131 I) posquirúrgica: ¿deberíamos modificar nuestra estrategia terapéutica?
    Maite Domínguez Ayala et al, 2018, Cirugía Española CrossRef
  13. BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer
    Yubing Tao et al, 2021, The Journal of Clinical Endocrinology & Metabolism CrossRef
  14. Younger Than 55 Years Old and BRAF V600E Mutation are Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinomas ≤1.0 cm but Not in >1.0 cm
    Yeqian Lai et al, 2023, International Journal of General Medicine CrossRef
  15. Gene mutations as predictors of central lymph mode metastasis in cN0 PTC: A meta‐analysis
    Jiaqi Ji et al, 2024, Clinical Genetics CrossRef